Literature DB >> 10030716

A model-based evaluation of the national immunization programme against rubella infection and congenital rubella syndrome in The Netherlands.

O G van der Heijden1, M A Conyn-van Spaendonck, A D Plantinga, M E Kretzschmar.   

Abstract

In order to improve the prevention of cases of congenital rubella syndrome in The Netherlands, in 1987 the selective vaccination strategy against rubella infection in girls was replaced by mass vaccination. This decision was supported by mathematical model analyses carried out by Van Druten and De Boo. In order to compare the predicted impact of the rubella vaccination programme with the current available data in more detail, a similar model was built. Although the model predicts elimination of the rubella virus, data show that virus circulation is still present at a higher level than expected by the model. Simulation studies indicate that import of infection and a lower vaccine effectiveness, related to possible asymptomatic reinfection of vaccinated people, could be sources contributing to the present virus circulation. Even though the number of infections is much higher than the number of reported cases of disease, limited serosurveillance data and case notification data show that females of childbearing age are well protected by immunization.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10030716      PMCID: PMC2809574          DOI: 10.1017/s0950268898001472

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  4 in total

1.  Impact of birth rate, seasonality and transmission rate on minimum levels of coverage needed for rubella vaccination.

Authors:  C J E Metcalf; J Lessler; P Klepac; F Cutts; B T Grenfell
Journal:  Epidemiol Infect       Date:  2012-02-16       Impact factor: 4.434

2.  Characterizing the dynamics of rubella relative to measles: the role of stochasticity.

Authors:  Ganna Rozhnova; C Jessica E Metcalf; Bryan T Grenfell
Journal:  J R Soc Interface       Date:  2013-09-11       Impact factor: 4.118

3.  Balancing evidence and uncertainty when considering rubella vaccine introduction.

Authors:  Justin Lessler; C Jessica E Metcalf
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240

4.  Reconstructing the transmission dynamics of rubella in Japan, 2012-2013.

Authors:  Masaya M Saito; Hiroshi Nishiura; Tomoyuki Higuchi
Journal:  PLoS One       Date:  2018-10-17       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.